Remove topic outsourcing
article thumbnail

A tough 2024 is on the horizon. Here's how Deloitte says healthcare leaders should prepare

Fierce Healthcare

Many of the past year’s buzziest topics and omnipresent struggles will likely rear their heads as major talking points across 2024, per the year-ahead predictions of Deloitte’s healthcare industry | Generative AI, outsourcing and skilled labor retention are among the focal points provider and payer executives will need to keep in their crosshairs.

134
134
article thumbnail

STAT+: Novo’s Catalent deal is great for GLP-1s. But what about drug manufacturing?

STAT

But Monday’s announcement that the parent company of Novo Nordisk, the maker of the weight loss drug Wegovy, plans to buy Catalent , a company to which drugmakers outsource manufacturing, is probably even more important than it seems. Sixteen billion dollars is a lot of money. Continue to STAT+ to read the full story…

Vaccines 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Manufacturing and Packaging Congress 2021

pharmaphorum

The business program will cover the following topics: New models for pharma manufacturing and packaging; Technology equipment in manufacturing; Key trends and new standards in pharma packaging; AI and digital development in manufacturing; Smart pharma packaging technologies; Manufacturing continuous production and its regulations; Personalized pharmaceutical (..)

article thumbnail

mRNA: A New Era in Biopharmaceutical Contract Manufacturing Market

Roots Analysis

However, owing to the several challenges associated with the production of mRNA-based therapeutics / vaccines , majority of the pharmaceutical companies prefer to outsource their manufacturing operations.

article thumbnail

Cell Therapy and Gene Therapy Contract Research Organizations: The Next Growth Opportunity

Roots Analysis

As a result, outsourcing has emerged as an essential aspect in the development and manufacturing of ATMPs. You can also download the SAMPLE REPORT on this topic by Roots Analysis by clicking here. It is worth highlighting that, in 2021, a sum of over USD 70 billion was invested in the cell and gene therapy domain.

40
article thumbnail

Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality

Roots Analysis

What are the Benefits of Outsourcing Biopharmaceutical Manufacturing? Currently, a significant number of players engaged in the biopharmaceutical domain prefer to outsource various operations to contract service providers. The below given figure provides an illustrative summary of the various types of biopharmaceuticals.

40
article thumbnail

Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality

Roots Analysis

What are the Benefits of Outsourcing Biopharmaceutical Manufacturing? Currently, a significant number of players engaged in the biopharmaceutical domain prefer to outsource various operations to contract service providers. The below given figure provides an illustrative summary of the various types of biopharmaceuticals.

40